Clinical trial Recruiting at 1 site Interventional Ages 18 to 45

Improving cardiometabolic health through circadian interventions

Official title: Timing of Circadian Synchronizers: The TOCS Study

Run by University of Utah · NCT05943626 · Data updated 2026-11-12

This study is testing whether changing sleep habits and reducing nighttime light and eating can help people with overweight and obesity who don’t get enough sleep improve their health over eight weeks.

Quick facts

Study typeInterventional
Ages18 Years to 45 Years
SexAll
Enrollment20 (estimated)
SponsorUniversity of Utah
Academic / other
Locations1 site (Salt Lake City, Utah)
StatusRecruiting
StartedJune 13, 2023
Main results expectedDecember 2026
Study endsJune 2027
Registry record updatedAugust 5, 2026
Trial IDNCT05943626 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 18-45 with a BMI between 25.0-34.9 and who report sleeping less than 6.5 hours per night.

Probably not a fit

Patients with clinically diagnosed sleep disorders, significant organ dysfunction, or those currently pregnant may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study examines the effectiveness of a circadian intervention aimed at improving cardiometabolic health in individuals with overweight and obesity who experience habitual short sleep duration. Participants will be randomly assigned to either a circadian intervention group, which focuses on reducing nighttime light exposure and late-night eating, or a control group that receives basic health information. The study will monitor sleep duration and assess insulin sensitivity through various tests over an 8-week period. The goal is to determine if adjusting circadian rhythms can lead to better health outcomes.

Why it matters

Potential benefit: If successful, this intervention could lead to improved cardiometabolic health and better management of conditions like Type 2 diabetes.

How similar studies have gone: While the specific approach of this study may be novel, similar interventions focusing on circadian rhythms have shown promise in improving health outcomes in other studies.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Age: 18-45 years old; equal numbers of men and women
2. Body mass index (BMI): 25.0-34.9 kg/m2,
3. Sleep Habits: habitual self-reported average total sleep time (TST) \<6.5 hours per night for prior 6 months

Exclusion Criteria:

1. Clinically diagnosed sleep disorder or major psychiatric illness
2. Evidence of significant organ dysfunction or disease (e.g., diagnosed diabetes, cardiovascular disease, or kidney disease)
3. Use of prescription drugs or substances known to influence sleep or glucose metabolism
4. Shift-work: current or history of within last year
5. Weight change: \>10% of body weight over prior six months
6. Experiencing menopause or post-menopausal
7. Current enrollment in weight loss or physical activity program like the Diabetes Prevention Program
8. Currently pregnant or planning to become pregnant, or currently lactating.
9. Currently smoking
10. Alcohol intake \>3 drinks per day or \>14 drinks per week

Where it's running

  • College of Health Research Complex--University of Utah
    Salt Lake City, Utah, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.